- Home
- MDGL vs LAMR Comparison
MDGL vs LAMR Comparison
Compare MDGL & LAMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | LAMR |
|---|---|---|
| Founded | 2011 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 13.7B |
| IPO Year | 2005 | 1999 |
Fundamental Metrics
Financial Performance| Metric | MDGL | LAMR |
|---|---|---|
| Price | $497.82 | $148.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $674.45 | $136.00 |
| AVG Volume (30 Days) | 254.7K | ★ 563.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.74% |
| EPS Growth | 41.32 | ★ 63.92 |
| EPS | N/A | ★ 1.00 |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.39 | $6.47 |
| Revenue Next Year | $48.55 | $3.77 |
| P/E Ratio | ★ N/A | $151.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $265.00 | $113.40 |
| 52 Week High | $615.00 | $158.69 |
Technical Indicators
Market Signals| Indicator | MDGL | LAMR |
|---|---|---|
| Relative Strength Index (RSI) | 44.46 | 62.97 |
| Support Level | $461.99 | $123.78 |
| Resistance Level | $502.97 | N/A |
| Average True Range (ATR) | 20.67 | 3.77 |
| MACD | -4.06 | 1.56 |
| Stochastic Oscillator | 12.36 | 59.91 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About LAMR Lamar Advertising Company
Lamar Advertising Co is an outdoor advertising company that operates as a real estate investment trust. It is engaged in the outdoor advertising business, operating outdoor advertising displays and logo signs mainly near highway exits, delivering brand-name information on available gas, food, lodging, and camping services. Included in the company's logo sign business are tourism signing contracts. It also provides transit advertising services in airport terminals, on bus shelters, benches, and buses. The company manages its operations through three operating segments: Billboard, which generates maximum revenue, Logo, and Transit Advertising. Geographically, it operates in the United States and Canada.